🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new initiative, Catalyst, continues to focus on improving health outcomes. Our partnerships with MyOme & Broad Clinical Labs allow us to work together to provide patients with free genome sequencing, polygenic risk scores, & improved healthcare access: southernresearch.org/myome-and-broa…

We can now sequence your whole genome for ~1% of the annual per capita healthcare budget of $14k. Analyzing your genetic and clinical data with AI, we can predict your disease risk far better than we could a few years ago. #Myome in partnership with #BroadClinicalLabs

Natera, MyOme Partner to Launch Cross-Ancestry, Integrated Breast Cancer Polygenic Risk Score genomeweb.com/molecular-diag…

Premal S. Shah, PhD, CEO is excited to speak at #PMWC2025 on Feb 6 at 2 PM. We'll discuss integrated polygenic risk scores for breast cancer & coronary artery disease. Learn more: pmwcintl.com/program/ #PrecisionMedicine

We're partnering with Novi Health to bring whole genome testing to employer health programs! Employees and their families can access single-gene risk, PGx reports, integrated risk (PRS) reports, and expert genetic counseling. Read more in our PR here: prnewswire.com/news-releases/…

Our chairman, Matthew Rabinowitz, will be giving the Keynote Speech titled "The Power of a Blood Sample" at #PMWC25 this Thursday, February 6th at 4:30 PM.

Our next roundtable explores challenges in clinical testing for #oncology & #raredisease including how to integrate & analyze multi-modal datasets. hubs.ly/Q0357s9s0 Ben Busby! Premal S. Shah MyOme Myriad Genetics Labcorp

Congratulations to our executive chairman and co-founder Matthew Rabinowitz, who was celebrated yesterday as a Luminary Honoree at the Precision Medicine World Conference - Precision Medicine World Conference. In accepting his award, Matt delivered a keynote presentation to a packed room entitled "The Power of a

MyOme’s Dr. Akash Kumar will speak at WashU Medicine’s Rare Disease Day event on: 📅 Feb 20 | 1:45PM PT / 3:45PM CT 🧬 Shortening Diagnostic Timelines for Rare Diseases – A Whole-Genome Platform Approach

We’ve gathered an expert panel to discuss clinical testing innovations & how #diagnostics orgs can bridge the gap between research, #drugdevelopment, healthcare providers & patients. hubs.ly/Q036jg3q0 Ben Busby! Premal S. Shah MyOme Myriad Genetics Labcorp

Looking forward to sharing the great work of the MyOme team. This is an exciting time in genomics and will discuss how make it less intimidating and applicable to all.

💡 Could preventive genomic medicine save $200 billion in healthcare costs? MyOme co-founder Matthew Rabinowitz explains how tools like whole #genomesequencing & #polygenicriskscores are shifting #medicine from reactive to proactive. 🎧 DNA Today Ep. 329: dnapodcast.com/episodes/2025/…

Our next roundtable covers the challenges & strategies for integrating vast, multi-modal datasets into #diagnostics organizations clinical testing workflows. hubs.ly/Q0357tQq0 Ben Busby! Premal S. Shah MyOme Myriad Genetics Labcorp

This is deeply personal for me. The MyOme team launched our Coronary Artery Disease (CAD) integrated PRS (iPRS) today with immediate availability. All PRS scores and reports are the not the same. We integrate relevant clinical factors—those you collect routinely during your

Today we are excited to launch CAD iPRS — a cutting-edge, genome-wide polygenic risk score for coronary artery disease. Empowering primary care to identify high-risk patients and personalize prevention strategies. Read more here: prnewswire.com/news-releases/…

Heart disease is still the biggest killer, more than all cancers combined. 47% of adults are at risk for heart disease and we can do far better than the current metrics based on clinical data. MyOme's CAD iPRS changes everything. Data-driven risk detection = huge cost

To the incredible teams at Natera and MyOme: Your tireless and brilliant work is shaping the future of healthcare in the US and beyond. Thank you. #EmployeeAppreciationDay

Join us at #ACMG2025 We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR

Excited to be announce our Rare Disease Diagnostic Portfolio—powered by whole genome sequencing to transform rare disease testing. Learn more: lnkd.in/gKcXcTze

MyOme is at #PM2025! Find us at Booth #11 today and tomorrow to: 🔬 See how we're using whole genome sequencing to transform preventive medicine. 💡 Learn how our approach to precision genomics is reshaping personalized care. Let’s connect! #PreventativeMedicine #GeneticTesting